Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Y M, Deo"'
Publikováno v:
The Journal of Immunology. 158:872-879
A bispecific fusion protein (H22-EGF) that binds simultaneously to the epidermal growth factor receptor (EGF-R) and to the high affinity receptor for the Fc portion of human IgG, Fc gammaRI (CD64), has been successfully constructed and expressed. For
Publikováno v:
Blood. 94(6)
Cross-linking of Fc receptors for IgA, FcalphaR (CD89), on monocytes/macrophages is known to enhance phagocytic activity and generation of oxygen free radicals. We provide evidence here that the FcalphaR signals through the gamma subunit of Fcepsilon
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(9)
A bispecific antibody was made by chemical conjugation of Fab' fragments from humanized antibodies specific for tumor-associated glycoprotein-72 (TAG-72) and high-affinity immunoglobulin receptor, FcgammaA receptor type I (FcgammaRI). The purified an
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 160(4)
The FcR for IgA (Fc alpha RI, CD89) is primarily expressed on cytotoxic immune effector cells. By chemically cross-linking F(ab') fragments of the FcR for IgA (Fc alpha RI)-specific mAb (A77) with tumor Ag-specific mAb (anti-HER2/neu and anti-epiderm
Autor:
T, Valerius, B, Stockmeyer, A B, van Spriel, R F, Graziano, I E, van den Herik-Oudijk, R, Repp, Y M, Deo, J, Lund, J R, Kalden, M, Gramatzki, J G, van de Winkel
Publikováno v:
Blood. 90(11)
Promising results from clinical trials with unconjugated antibodies stimulated renewed interest in immune effector mechanisms of monoclonal antibodies (MoAbs). We investigated the potential of IgA as antibody isotype for cell- or complement-mediated
Autor:
T, Keler, R F, Graziano, A, Mandal, P K, Wallace, J, Fisher, P M, Guyre, M W, Fanger, Y M, Deo
Publikováno v:
Cancer research. 57(18)
A bispecific antibody, MDX-H210, was developed to target cytotoxic effector cells expressing Fc gamma receptor type I (Fc gammaRI, CD64) to HER2/neu-overexpressing tumor cells. HER2/neu is an appropriate target for immunotherapy due to the high level
Autor:
B, Stockmeyer, T, Valerius, R, Repp, I A, Heijnen, H J, Bühring, Y M, Deo, J R, Kalden, M, Gramatzki, J G, van de Winkel
Publikováno v:
Cancer research. 57(4)
Immunotherapies directed to the proto-oncogene product HER-2/neu, which is overexpressed on a subset of breast and other carcinomas, currently receive considerable attention. We have investigated cell-mediated effector mechanisms of HER-2/neu antibod
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 158(2)
A bispecific fusion protein (H22-EGF) that binds simultaneously to the epidermal growth factor receptor (EGF-R) and to the high affinity receptor for the Fc portion of human IgG, Fc gammaRI (CD64), has been successfully constructed and expressed. For
Autor:
M K, Gorny, T, Keler, S, Burda, C, Williams, J L, Gabriel, W M, Mitchell, Y M, Deo, S, Zolla-Pazner
Publikováno v:
Antibiotics and chemotherapy. 48
Autor:
G. M. Gaucher, Y. M. Deo
Publikováno v:
Biotechnology Letters. 5:125-130
Conidia of Penicillium urticae, immobilized in κ-carrageenan beads, were germinated in situ to form a patulin producing cell mass by incubating these beads in a growth supporting medium. When these in situ grown immobilized cells were repeatedly tra